Investigation of enterovirus infections, autoimmune factors and HLA genotypes in patients with T1DM

Minerva Endocrinologica

Volumn 39, Issue 1, 2014, Pages 67-74

  Cekin Y ^a   Ozkaya E ^b   Gulkesen H ^c   Akcurin S ^c   Colak D ^d  

^a ANTALYA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Department of Virology Refik Saydam Hifsisihha Center   (Turkey)

^c AKDENIZ UNIVERSITY   (Turkey)

^d Akdeniz Medical Microbiology Department University School of Medicine   (Turkey)

Author keywords

Diabetes mellitus type 1; Enterovirus; Glutamate decarboxylase

Indexed keywords

COXSACKIE VIRUS B4 ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS RNA;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; COXSACKIE VIRUS B4; ENTEROVIRUS INFECTION; GENOTYPE; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PATHOGENESIS; TURKEY (REPUBLIC);

ADOLESCENT; ANTIBODIES, VIRAL; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; CHILD; COXSACKIEVIRUS INFECTIONS; DIABETES MELLITUS, TYPE 1; DISEASE SUSCEPTIBILITY; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMATE DECARBOXYLASE; HLA ANTIGENS; HUMANS; MALE; MOLECULAR MIMICRY; RNA, VIRAL; TURKEY; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84898738243     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Van Der Werf N, Kroese FG, Rozing J, Hillebrands JL. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 2007;23:169-83. (Pubitemid 46437842)
2. Eiselein L, Schwartz HJ, Rutledge JC. The challenge of type 1 diabetes mellitus. ILAR J 2004;45:231-6.
3. Bopegamage S, Kovacova J, Vargova A, Motusova J, Petrovicova A, Benkovicova M et al. Coxsackie B Virus Infection Of Mice: inoculation by the oral route protects the pancreas from damage, but not from infection. J Gen Virol 2005;86(Pt 12):3271-80. (Pubitemid 41685159)
4. Onkamo P, Väänänen S, Karvonen M, Tuomilheto J. Worldwide increase in incidence of Type 1 diabetes - the analysis of the data on published incidence trends. Diabetologia 1999;42:1395-403. (Pubitemid 30012309)
5. Akesen E, Turan S, Güran T, Atay Z, Save D, Bereket A. Prevalence of type 1 diabetes mellitus in 6-18-yr-old school children living in Istanbul, Turkey. Pediatr Diabetes 2011;12:567-71.
6. Hatun S. Çocukluk çaǧinda diyabet. Çocuk Endokrinoloji Dergisi 2003;1:15-8.
7. Pitkäniemi J, Onkamo P, Tuomilheto J, Arjas E. Increasing incidence of Type 1 diabetes - role for genes? BMC Genet 2004;5:5-18.
8. O'connell Ma, Donath S, Cameron Fj. Major increase in Type 1 diabetes - no support for the Accelerator Hypothesis. Diabet Med 2007;24:920-3.
9. st edition. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 411-26.
10. Jaïdane H, Sané F, Gharbi J, Aouni M, Romond Mb, Hober D. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab Res Rev 2009;25:591-603.
11. Tracy S, Drescher Km, Jackson Jd, Kim K, Kono K. Enteroviruses, type 1 diabetes and hygiene: a complex relationship. Rev Med Virol 2010;20:106-16.
12. Buesa-Gomez J, De La Torre Jc, Dyrberg T, Landin-Olsson M, Mauseth RS, Lernmark A et al. Failure to detect genomic viral sequences in pancreatic tissues from two children with acute-onset diabetes mellitus. J Med Virol 1994;42:193-7.
13. Hyoty H. Environmental causes: viral causes. Endocrinol Metab Clin North Am 2004;33:27-44. (Pubitemid 38438422)
14. Richer MJ, Horwitz MS. Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes. Autoimmun Rev 2009;8:611-5.
15. Viskari Hr, Koskela P, Lonnrot M, Luonuansuu S, Reunanen A, Baer M et al. Can enterovirus infections explain the increasing incidence of type 1 diabetes? Diabetes Care 2000;23:41-7.
16. Lonnrot M, Knip M, Marciulionyte D, Rahko J, Urbonaite B, Moore WP et al. Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care 1999;22:2086-8. (Pubitemid 30433996)
17. Viskari H, Ludvigsson J, Uibo R, Salur L, Marciulionyte D, Hermann R et al. Relationship between the incidence of type 1diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia 2005;48:1280-7. (Pubitemid 41186091)
18. Emekdaş G, Rota S, Kuştimur S, Kocabeyoǧlu O. Antibody levels against coxsackie B viruses in patients with type 1 diabetes mellitus. Mikrobiyol Bul 1992;26:116-20.
19. Green J, Casabonne D, Newton R. Coxsackie B virus serology and Type 1 diabetes mellitus:a systematic review of published case-control studies. Diabet Med 2004;21:507-14. (Pubitemid 38746267)
20. Clements GB, Galbraith DN, Taylor K. Coxsackie B virus infection and onset of childhood diabetes. Lancet 1995;346:221-3.
21. Moya-Suri V, Schlosser M, Zimmermann K, Rjasanowski I, Gürtler L, Mentel R. Enterovirus RNA sequences in sera of schoolchildren in the general population and their association with type 1-diabetes-associated autoantibodies. J Med Microbiol 2005;54(Pt 9):879-83. (Pubitemid 41216286)
22. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011;342:d35.
23. Hyöty H, Hiltunen M, Knip M, Laakkonen M, Vahasalo P, Karjailainen J. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 1995;44:652-7.
24. Salminen KK, Vuorinen T, Oikarinen S, Helminen M, Simell S, Knip M et al. Isolation of enterovirus strains from children with preclinical Type 1 diabetes. Diabet Med 2004;21:150-64.
25. Borg H, Marcus C, Sjoblad S, Fernlund P, Sundkvist G. Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/LA2 antibodies after diagnosis of diabetes. Acta Paediatrica 2000;89:46-51. (Pubitemid 30060629)
26. Bonifacio E, Lampasona V, Bernasconi L, Ziegler AG. Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes 2000;49:202-8. (Pubitemid 30070998)
27. Batstra MR, Pina M, Quan J, Mulder P, de Beaufort CE, Bruining GJ et al. Fluctuations in GAD65 antibodies after clinical diagnosis of IDDM in young children. Diabetes Care 1997;20:642-4. (Pubitemid 27143430)
28. Atkinson MA, Macleran NK. The pathogenesis of insulin dependent diabetes mellitus. N Engl J Med 1994;331:1428-36.
29. Haller MJ, Atkinson MA, Schatz D. Type 1 diabetes mellitus: etiology, presentation, and management. Pediatr Clin North Am 2005;52:1553-78. (Pubitemid 41654729)
30. Saruhan-Direskeneli G, Uyar Fa, Bas F, Günöz H, Bundak R, Saka N et al. HLA-DR and -DQ associations with insulin-dependent diabetes mellitus in a population of Turkey. Hum Immunol 2000;61:296-302.
31. Ozsahin H, Haktan M, Ozbakir F, Aydin A, Yazici H. The type 1 diabetes and HLA-DR in Turkey. Diabete Metab 1991;17:421-3.
32. Redondo MJ, Fain PR, Eisenbarth GS. Genetics of type 1A diabetes. Recent Prog Horm Res 2001;56:69-89.